Answers are grounded in this paper and cite their sources.
Introduction Choline metabolism-related genes (CMRGs) have been implicated in tumor progression; however, their pan-cancer roles and implications in oral squamous cell carcinoma (OSCC) remain poorly understood. In this study, we systematically examined the prognostic and immunological significance of CMRGs across cancers, with a focus on OSCC. Methods We analyzed CMRG data for 33 TCGA tumor types for pan-cancer differentially expressed genes (DEGs), genes associated with overall survival (OS), genetic variants, and Hallmark pathways. Univariate Cox regression analysis was used to identify OSCC prognostic genes, which were then cross-analyzed with DEGs to build a prognostic model. OSCC patients were divided into high-/low-risk groups by risk score, followed by independent prognostic analysis, immune infiltration assessment, and gene set enrichment analysis (GSEA). Validation was performed using RT-qPCR, Western blot, and immunohistochemistry on OSCC cell lines and tissue microarrays. Results CMRGs were differentially expressed in most cancer types, and risk-associated genes outnumbered protective genes in the prognostic analyses. Single-nucleotide variants, predominantly missense mutations, were detected in various tumors. The CMRG scores were significantly positively correlated with the PI3K-AKT-mTOR, heme metabolism, xenobiotic metabolism, and Hedgehog signaling pathways. MAPK9, PDGFA, PRKCA, and DGKH were used to construct an OSCC risk model. Time-dependent receiver operating characteristic analyses in the TCGA-OSCC training set and the GSE41613 validation cohort revealed moderate discrimination (AUC > 0.6). The risk score was associated with OSCC and was independently associated with prognosis in a multivariable Cox analysis. Further analyses revealed a lower ssGSEA score for activated CD8 + T cells in the high-risk group. The TIDE algorithm suggested that the predicted immunotherapy response was poorer in this group. Predicted IC 50 values also differed between the high/low-risk groups. Conclusion CMRGs are associated with expression patterns across multiple cancer types and prognostic features in OSCC. The four-gene signature (MAPK9/PDGFA/PRKCA/DGKH) derived from the database-annotated CMRG set was associated with OS and immune-related scores in OSCC and displayed a potential for risk stratification. This study provided a preliminary basis for further evaluating the biological basis of CMRG-related expression patterns and their value for OSCC risk stratification.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: